- Home
- SYM vs PTCT Comparison
SYM vs PTCT Comparison
Compare SYM & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYM | PTCT |
|---|---|---|
| Founded | 2005 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.3B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | SYM | PTCT |
|---|---|---|
| Price | $59.42 | $78.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 17 |
| Target Price | $53.00 | ★ $73.76 |
| AVG Volume (30 Days) | ★ 4.4M | 2.3M |
| Earning Date | 02-04-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 8.94 |
| Revenue | ★ $2,246,922,000.00 | $1,779,150,000.00 |
| Revenue This Year | $21.90 | $128.32 |
| Revenue Next Year | $28.00 | N/A |
| P/E Ratio | ★ N/A | $8.79 |
| Revenue Growth | 25.65 | ★ 97.54 |
| 52 Week Low | $16.32 | $35.95 |
| 52 Week High | $87.88 | $87.50 |
Technical Indicators
Market Signals| Indicator | SYM | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 45.92 | 57.21 |
| Support Level | $55.85 | $73.78 |
| Resistance Level | $63.89 | $76.17 |
| Average True Range (ATR) | 5.18 | 2.73 |
| MACD | -0.76 | -0.49 |
| Stochastic Oscillator | 14.20 | 68.52 |
Price Performance
Historical ComparisonAbout SYM Symbotic Inc.
Symbotic Inc is an automation technology company that develops technologies to improve operating efficiencies in modern warehouses. The group develops, commercializes, and deploys end-to-end technology solutions that dramatically improve supply chain operations. Th company also automates the processing of pallets and cases in large warehouses or distribution centers for some of the retail and wholesale companies in the world. The company operates in two geographical regions the United States and Canada. Key revenue is generated from the United States.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.